51 results
8-K
EX-1.1
CERE
Cerevel Therapeutics Holdings Inc
12 Oct 23
Cerevel Therapeutics Announces Proposed Public Offering of Common Stock
4:19pm
contemplated in this Agreement are consummated or this Agreement is terminated, to pay or cause to be paid all expenses incident to the performance of its … for the Underwriters pursuant to subsections (iii) and (iv) shall not exceed $25,000 in the aggregate, (v) all costs and
expenses incident to listing the Shares
8-K
EX-1.1
ciddos3whnlf49
12 Aug 22
Cerevel Therapeutics Announces Proposed Private Offering of Convertible Senior Notes
5:03pm
S-3
EX-1.2
o7f 6fq14
10 Nov 21
Shelf registration
7:27am
424B3
483uk3k0t8ul5oa 6ts9
10 Nov 21
Prospectus supplement
6:53am
424B3
y5b 3zu9kto
11 Aug 21
Prospectus supplement
4:30pm
424B4
5iku g1srjbhf6rky
2 Jul 21
Prospectus supplement with pricing info
5:22pm